Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG

NCT: NCT07844434 · NOT_YET_RECRUITING

NCT IDNCT07844434
StatusNOT_YET_RECRUITING
Start Date2026-08-30
Completion2028-03-30
SponsorInha University Hospital (OTHER)
First posted
Last updated

Brief Summary

This pilot study is designed to evaluate the clinical performance and utility of the SmartECG-EF software in patients undergoing evaluations at Inha University Hospital. The primary objective is to assess how effectively the device assists clinicians in evaluating cardiac function and related clinical parameters. The study will prospectively enroll eligible participants to gather real-world clinical data, contributing to enhanced diagnostic accuracy and patient management.

Frequently Asked Questions

What is AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG?

AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG is a clinical trial registered under NCT07844434. Current status: NOT_YET_RECRUITING.

What is the status of NCT07844434?

The current status of NCT07844434 (AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG) is: NOT_YET_RECRUITING.

When did AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG start?

AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG started on 2026-08-30.

Related Devices

K253801ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)Anumana, Inc. K252360ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)Anumana, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑